戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 in addition to routine NHS physiotherapy and occupational therapy.
2 re, respiratory medicine, physiotherapy, and occupational therapy.
3 s required, and providing early physical and occupational therapy.
4 ncology, nutrition, speech, and physical and occupational therapy.
5 who provide their patients with psychosocial occupational therapy.
6 ovision that may or may not include standard occupational therapy.
7 ceipt of neuroimaging services, and physical/occupational therapy.
8 83), and in black patients physiotherapy and occupational therapy (0.32, 0.11 to 0.92).
9 representation in the current workforce (eg, occupational therapy: 0.31 vs 0.50).
10 tidisciplinary care (-1.98, -3.80 to -0.16), occupational therapy (-2.59, -4.70 to -0.40), exercise c
11 ntilated patients receiving physical therapy/occupational therapy (48% vs 26%; p </= 0.001).
12 er-level utilization of physical therapy and occupational therapy among critically ill patients was u
13 [9.1] years), 381 received physiotherapy and occupational therapy and 381 received no therapy.
14 consensus recommendations for physiotherapy, occupational therapy and outcome measures also published
15 managing the symptoms through physiotherapy, occupational therapy and speech therapy.
16 sedative interruption and early physical and occupational therapy and to specify details of intensive
17 assessment, nurse assessment, physiotherapy, occupational therapy, and assessment of communication an
18 utpatient services, including physiotherapy, occupational therapy, and multidisciplinary teams.
19 uncture, chiropractic care, massage therapy, occupational therapy, and physical therapy).
20 t care, involving nursing, physical therapy, occupational therapy, and respiratory therapy practition
21      It is unclear whether physiotherapy and occupational therapy are clinically effective and cost-e
22                                 Physical and occupational therapy are possible immediately after intu
23   Rehabilitative interventions (physical and occupational therapy) are treatments of choice for funct
24                          Providing community occupational therapy as delivered in this study did not
25  (0.18% per quarter; P=0.027), physiotherapy/occupational therapy assessment (0.25% per quarter; P<0.
26 e by providing consensus recommendations for occupational therapy assessment and intervention.
27 oup (n=184) underwent a detailed medical and occupational-therapy assessment with referral to relevan
28 were allocated randomly to up to 5 months of occupational therapy at home or to no intervention (cont
29 rgical options, as well as physiotherapy and occupational therapy, but evidence is inconclusive for m
30                                              Occupational therapy can improve activities of daily liv
31 pairment measures, performance testing in an occupational therapy clinic, and performance testing in
32 ollaborative care plus 2 years of home-based occupational therapy delays functional decline.
33 ollaborative care plus 2 years of home-based occupational therapy delays functional decline.
34 the intervention group also received in-home occupational therapy delivered in 24 sessions over 2 yea
35 eceive COTiD-UK, which comprised 10 hours of occupational therapy delivered over 10 weeks in the pers
36 on Program [ASAP]; n = 119); dose-equivalent occupational therapy (DEUCC; n = 120); or monitoring-onl
37 arly exercise and mobilisation (physical and occupational therapy) during periods of daily interrupti
38 dative interruption followed by physical and occupational therapy every hospital day until achieving
39                           Several aspects of occupational therapy for FND are distinct from therapy f
40 mate the clinical effectiveness of Community Occupational Therapy for people with dementia and family
41 of tDCS while undergoing usual care physical/occupational therapy for the arm and hand.
42        185 patients were included: 94 in the occupational therapy group and 91 in the control group.
43           At 6 months the improvement in the occupational therapy group was significantly greater tha
44               At follow-up, patients who had occupational therapy had significantly higher median sco
45 istered home safety assessment, and targeted occupational therapy home visits with home hazard remova
46 ntia and family carers-UK version (Community Occupational Therapy in Dementia-UK version [COTiD-UK])
47 nt-centered, goal-directed physiotherapy and occupational therapy in patients in the early stages of
48 of interruption of sedation and physical and occupational therapy in the earliest days of critical il
49 es have demonstrated that early physical and occupational therapy, including during the period of int
50 ht self-management strategies are central to occupational therapy intervention for FND.
51        We aimed to assess the efficacy of an occupational therapy intervention for patients with stro
52                      Targeted, comprehensive occupational therapy intervention improves functional an
53 ivity in employed patients with RA receiving occupational therapy intervention versus usual care.
54 or research aiming to develop evidence-based occupational therapy interventions for people with FND.
55 ified 46 unique original research studies of occupational therapy interventions; the most common stud
56                             Physical therapy/occupational therapy involvement in mobility events was
57                             Physical therapy/occupational therapy involvement in mobility was strongl
58                           Early physical and occupational therapy is feasible from the onset of mecha
59 Podiatry, and, to a lesser extent, Pharmacy, Occupational Therapy, Logopedia, and Biomedical Engineer
60 tilated patients received early physical and occupational therapy occurring a median of 1.5 days (ran
61 ization protocols include dedicated physical/occupational therapy (odds ratio, 3.34; 95% CI, 2.13-5.2
62 y interruption of sedation with physical and occupational therapy on functional outcomes in patients
63 as created by a team representing optometry, occupational therapy, ophthalmology, neuropsychology, an
64 ge group knew about coverage for physical or occupational therapy or for assistive devices.
65 g (ADL) were randomized to physiotherapy and occupational therapy or no therapy.
66 omly assigned to receive either psychosocial occupational therapy or skills training for 12 hours wee
67 izophrenia after treatment with psychosocial occupational therapy or social skills training, with the
68 h-risk (>or=17) groups, then randomized into occupational therapy or usual care groups.
69 was delivery of physical therapy (PT) and/or occupational therapy (OT) during ICU hospitalization, ch
70  (88%) required physical therapy (PT) and/or occupational therapy (OT).
71 f more structured and intensive physical and occupational therapy programs in patients with all stage
72 The point prevalence of physical therapy- or occupational therapy-provided mobility during 1,769 pati
73 portion of patient-days with any physical or occupational therapy-provided mobility event.
74 tcome was prevalence of physical therapy- or occupational therapy-provided mobility on the study days
75           The prevalence of physical therapy/occupational therapy-provided mobility was 32% (247/770)
76 spiratory failure patients, physical therapy/occupational therapy-provided mobility was infrequent.
77                                 Physical and occupational therapy (PT/OT) during invasive mechanical
78   Symptomatic care and rigorous physical and occupational therapy remain critical components of a com
79 ponent, counseling, exercise, music therapy, occupational therapy, reminiscence therapy, social inter
80  from 81% utilization of physical therapy or occupational therapy services among high utilization cen
81 e not charged for either physical therapy or occupational therapy services.
82 ral tablet 45-60 min before physiotherapy or occupational therapy session.
83 ring 15% (n = 26 of 168) of all physical and occupational therapy sessions (median distance of 15 fee
84 e edge of the bed in 69% of all physical and occupational therapy sessions, transferred from bed to c
85 sterase inhibitor together with physical and occupational therapy significantly improved the patient'
86                                              Occupational therapy significantly reduced disability an
87 had low rates of inpatient physical therapy, occupational therapy, speech and language pathology, and
88 rted presence of a dedicated physical and/or occupational therapy team for the ICU.
89 verse needs of ICU patients and the scope of occupational therapy, there could be an opportunities fo
90 e whether the addition of 2 years of in-home occupational therapy to a collaborative care management
91 e whether the addition of 2 years of in-home occupational therapy to a collaborative care management
92                            We recommend that occupational therapy treatment for FND is based on a bio
93 therapy (DEUCC; n = 120); or monitoring-only occupational therapy (UCC; n = 122).
94 rimary care visits, physical therapy visits, occupational therapy visits, and home healthcare visits
95   Extensive rehabilitation with physical and occupational therapy was required for several months.
96                               The aim of the occupational therapy was to encourage independence in pe
97                            Physiotherapy and occupational therapy were not associated with immediate